Aprea Therapeutics
APRE
APRE
24 hedge funds and large institutions have $10.8M invested in Aprea Therapeutics in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
18.22% more ownership
Funds ownership: 25.24% → 43.46% (+18%)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.81M | |
| 2 | +$1.38M | |
| 3 | +$1.23M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$918K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$544K |
Top Sellers
| 1 | -$410K | |
| 2 | -$376K | |
| 3 | -$274K | |
| 4 |
Morgan Stanley
New York
|
-$51K |
| 5 |
SCM
Sio Capital Management
New York
|
-$22.7K |